Load Balancing Approach to Mitigating the Impact of DDoS Attack

Fatima Enehezei Usman‐Hamza, Ghaniyyat B. Balogun, Shaibu Muhammed Etudaye, Shakirat Aderonke Salihu, Peter O. Sadiku, Rafiat A. Oyekinle, Abdulrauf O. Babatunde, and Amos Orenyi Bajeh,

KeywordsAssessment, Anti-psychotic Medication, Barriers, Schizophrenia, Jigawa


Achieving complete remission of symptoms is rare, especially in schizophrenia and some other mental illnesses like, Bipolar Affective Disorder (BAD. Several studies have indicated that poor access to antipsychotic drugs results in non-adherence that will invariably leads to poor quality of life among schizophrenic patients.


Aim: This study aimed to assess the barriers of access to Anti-psychotic Medications among patients with Schizophrenia in some selected Hospitals of Jigawa State, Nigeria.

Methodology: A hospital based cross-sectional descriptive study design was used with a total of four hundred and thirty-six (436) schizophrenic patients receiving treatment from some selected hospitals. Participants were recruited through multi-stage sampling and questionnaire were administered. Data collected was entered, coded and analyzed using the Statistical Package for the Social Sciences (SPSS) version 22.

Result: About one third (34.1%) of the study participants have good access to, while about two third (65.9%) of the study participants have poor or no access to drugs. After anti-psychotic medications; adjusting for the confounding effects using logistic regression analysis; educational status of secondary (AOR=0.4,95%CI=0.19-0.84) and tertiary (AOR=0.25,95%CI=0.13-0.97), marital status of single (AOR=4.25, 95%CI=1.79-9.31), occupational status of civil servants category (AOR=0.40, 95%CI=(1.13 – 5.68), sex of male category (AOR=0.33, 95%CI= (0.11 – 0.72)) remained significant predictors of low barrier to access of anti-psychotic medications.

Conclusions: Supervised community treatment can be introduced to an individual to ensure continual acceptance of antipsychotic medication following hospital discharge and encourage community collaborative approach in the management of the schizophrenic patients. This will help to increase accessibility to drugs.